Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) expression during cardiac neural crest cell migration and its role in ProMMP-2 activation

Developmental Dynamics

Volumn 231, Issue 4, 2004, Pages 709-719

  Cantemir, V ^a   Cai, D H ^a,c   Reedy, M V ^b   Brauer, P R ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cell migration; Embryology; Metalloproteinase; Neural crest; Tissue inhibitors of metalloproteinases

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME LOCALIZATION; HEART; HEART MUSCLE; MORPHOGENESIS; NEURAL CREST CELL; NONHUMAN; NOTOCHORD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL MOVEMENT; CHICK EMBRYO; CHICKENS; EMBRYO, NONMAMMALIAN; ENZYME PRECURSORS; GELATINASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; METALLOENDOPEPTIDASES; NEURAL CREST; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

GALLUS GALLUS;

EID: 11144268173     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.20171     Document Type: Article

References (64)

1. Blavier L, Henriet P, Imren S, DeClerck YA. 1999. Tissue inhibitors of matrix metalloproteinases in cancer. Ann N Y Acad Sci 878:108-119.
2. Blavier L, Lazaryev A, Groffen J, Heisterkamp N, DeClerck YA, Kaartinen V. 2001. TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell 12:1457-1466.
3. Brauer PR, Cai DH. 2002. Expression of tissue inhibitors of metalloproteinases (TIMPs) during early cardiac development. Mech Dev 113:175-179.
4. Brauer PR, Bolender DL, Markwald RR. 1983. Migration of neural crest along preferred extracellular matrical pathways. Anat Rec 205:23A.
5. Brew K, Dinakarpandian D, Nagase H. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267-283.
6. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683-693.
7. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP, Murphy G, 1998. The TIMP-2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273:871-880.
8. Butler GS, Apte SS, Willenbrock F, Murphy G. 1999. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J Biol Chem 274:10846-10851.
9. Cai DH, Brauer PR. 2002. A synthetic matrix metalloproteinase inhibitor decreases early cardiac neural crest migration in chicken embryos. Dev Dyn 224:441-449.
10. Cai DH, Vollberg TM Sr, Hahn-Dantona E, Quigley JP, Brauer PR. 2000. MMP-2 expression during early avian cardiac and neural crest morphogenesis. Anat Rec 259:168-179.
11. Caterina JJ, Yamada S, Caterina NC, Longenecker G, Holmback K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H. 2000. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2 (TIMP-2) gene alters proMMP-2 activation. J Biol Chem 275:26416-26422.
12. Chen WT, Wang JY. 1999. Specialized surface protrusions of invasive cells, invadopodia and lamellipodla, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann N Y Acad Sci 878:361-371.
13. Chin JR, Werb Z. 1997. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 124:1519-1530.
14. Conway SJ, Bundy J, Chen J, Dickman E, Rogers R, Will BM. 2000. Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H))/Pax3 mouse mutant. Cardiovasc Res 47:314-328.
15. Coopman PJ, Do MT, Thompson EW, Mueller SC. 1998. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 4:507-515.
16. Delannet M, Martin F, Bossy B, Cheresh DA, Reichardt LF, Duband JL. 1994. Specific roles of the alpha V beta 1, alpha V beta 3 and alpha V beta 5 integrins in avian neural crest cell adhesion and migration on vitronectin. Development 120:2687-2702.
17. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A. 1997. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110:2473-2482.
18. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY. 2001. MT1-MMP initiates activation of pro-MMP-2 and integrin alpha v beta 3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263:209-223.
19. Duong TD, Erickson CA. 2004. MMP-2 plays an essential role in producing epithelial-mesenchymal transformations in the avian embryo. Dev Dyn 229:42-53.
20. Dupe V, Ghyselinck NB, Wendling O, Chambon P, Mark M. 1999. Key roles of retinoic acid receptors alpha and beta in the patterning of the caudal hindbrain, pharyngeal arches and otocyst in the mouse. Development 126:5051-5059.
21. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G, Moses MA. 2000. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A 97:3884-3889.
22. Fernandez CA, Butterfield C, Jackson G, Moses MA. 2003. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor. J Biol Chem 278:40989-40995.
23. Grapin-Botton A, Bonnin MA, Sieweke M, Le Douarin NM. 1998. Defined concentrations of a posteriorizing signal are critical for MafB/Kreisler segmental expression in the hindbrain. Development 125:1173-1181.
24. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R. 2000. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275:12080-12089.
25. Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H, Allen ED, Hiraoka N, Weiss SJ. 2002. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp Med 195:295-308.
26. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. 2003. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114:33-45.
27. Imai K, Shikata H, Okada Y. 1995. Degradation of vitronectin by matrix metalloproteinases-1, -2, -3, -7 and -9. FEBS Lett 369:249-251.
28. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. 1997. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta 1 release. Biochem J 322(Pt 3):809-814.
29. Jo Y, Yeon J, Kim HJ, Lee ST. 2000. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Biochem J 345:511-519.
30. Kirby ML. 1987. Cardiac morphogenesis - recent research advances. Pediatr Res 21:219-224.
31. Kirby ML. 1989. Plasticity and predetermination of mesencephalic and trunk neural crest transplanted into the region of the cardiac neural crest. Dev Biol 134:402-412.
32. Kirby ML, Gale TL, Steward DE. 1983. Neural crest cells contribute to normal aorticopulmonary septation. Science 220:1059-1061.
33. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R. 1999. Tumor targeting with a selective gelatinase inhibitor. Nat Biotech 17:768-774.
34. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. 1994. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269:9352-9360.
35. Marin F, Charnay P. 2000. Hindbrain patterning: FGFs regulate Krox20 and mafB/kr expression in the otic/preotic region. Development 127:4925-4935.
36. Makela M, Larjava H, Pirila E, Maisi P, Salo T, Sorsa T, Uitto VJ. 1999. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 251:67-78.
37. Miettinen PJ, Chin JR, Shum L, Slavkin HC, Shuler CF, Derynck R, Werb Z. 1999. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 22:69-73.
38. Mignatti P, Rifkin DB. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195.
39. Morrison CJ, Butler GS, Bigg HF, Roberts CR, Soloway PD, Overall CM. 2001. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem 276:47402-47410.
40. Nagase H. 1997. Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
41. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT. 1997. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci U S A 94:7959-7964.
42. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H. 1990. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194:721-730.
43. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP. 1992. A new inhibitor of metalloproteinases from chicken: ChlMP-3, a third member of the TIMP family. J Biol Chem 267:17321-17326.
44. Perris R, Perissinotto D, Pettway Z, Bronner-Fraser M, Morgelin M, Kimata K. 1996. Inhibitory effects of PG-H/aggrecan and PG-M/versican on avian neural crest cell migration. FASEB J 10:293-301,
45. Pettway Z, Guillory G, Bronner-Fraser M. 1990. Absence of neural crest cells from the regions surrounding implanted notochords in situ. Dev Biol 142:335-346.
46. Pettway Z, Domowicz M, Schwartz NB, Bronner-Fraser M. 1996. Age-dependent inhibition of neural crest migration by the notochord correlates with alterations in the S103L chondroitin sulfate proteoglycan. Exp Cell Res 225:195-206.
47. Prontera C, Mariani B, Rossi C, Poggi A, Rotilio D. 1999. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int J Cancer 81:761-766.
48. Pulyaeva H, Bueno J, Polette M, Birembaut P, Sato H, Seiki M, Thompson EW. 1997. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 15:111-120.
49. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. 2003. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114:171-180.
50. Siri A, Knauper V, Veirana N, Caocci F, Murphy G, Zardi L. 1995. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270:8650-8654.
51. Song W, Jackson K, McGuire PG. 2000. Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. Dev Biol 227:606-617.
52. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338.
53. Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML, Brown S, Mobashery S, Fridman R. 2000. TIMP-2 acts synergistically with synthetic MMP inhibitors but not with TIMP-4 to enhance the MT1-MMP-dependent activation of pro-MMP-2. J Biol Chem 275:41415-41423.
54. Vassalli J-D, Pepper MS. 1994. Membrane proteases in focus. Nature 370:14-15.
55. Waldo K, Kirby ML. 1998. Development of the great arteries. In: de la Cruz MV, Markwald RR, editors. Living morphogenesis of the heart. Boston, MA: Birkhauser. p 187-217.
56. Wang Z, Juttermann R, Soloway PD. 2000. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275:26411-26415.
57. Werb Z, Chin JR. 1998. Extracellular matrix remodeling during morphogenesis. Ann N Y Acad Sci 857:110-118.
58. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271:17119-17123.
59. Witty JP, Wright JH, Matrisian LM. 1995. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 6:1287-1303.
60. Woessner JF Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.
61. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P. 2003. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160:267-277.
62. Yu WH, Yu S, Meng Q, Brew K, Woessner JF Jr. 2000. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 275:31226-31232.
63. Zhang J, Bai S, Tanase C, Nagase H, Sarras MP, Jr. 2003. The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos. Dev Genes Evol 213:382-389.
64. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J. 1998. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273:1216-1222.